GENWORTH FINANCIAL INC's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), GENWORTH FINANCIAL INC reported revenue of $7.3B (+0.1% year on year) and net income of $350.0M (-18.0% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Premiums | $3.5B | $3.5B | $3.6B | $3.7B |
| Net investment income | $3.1B | $3.2B | $3.2B | $3.1B |
| Net investment gains (losses) | $59.0M | $13.0M | $23.0M | ($17.0M) |
| Policy fees and other income | $618.0M | $642.0M | $646.0M | $659.0M |
| Total revenues | $7.3B | $7.3B | $7.5B | $7.5B |
| Benefits and other changes in policy reserves | $4.8B | $4.8B | $4.8B | $4.2B |
| Liability remeasurement (gains) losses | $313.0M | $153.0M | $587.0M | — |
| Changes in fair value of market risk benefits and associated hedges | $3.0M | ($13.0M) | ($12.0M) | — |
| Interest credited | $386.0M | $453.0M | $503.0M | $503.0M |
| Acquisition and operating expenses, net of deferrals | $1.0B | $977.0M | $942.0M | $1.4B |
| Amortization of deferred acquisition costs and intangibles | $231.0M | $249.0M | $264.0M | $307.0M |
| Interest expense | $105.0M | $115.0M | $118.0M | $106.0M |
| Total benefits and expenses | $6.9B | $6.7B | $7.2B | $6.5B |
| Income (loss) from continuing operations before income taxes | $433.0M | $595.0M | $303.0M | $978.0M |
| Provision (benefit) for income taxes | $84.0M | $158.0M | $104.0M | $239.0M |
| Income (loss) from continuing operations | $349.0M | $437.0M | $199.0M | $739.0M |
| Income (loss) from discontinued operations, net of taxes | $1.0M | ($10.0M) | $0 | $0 |
| Net income (loss) | $350.0M | $427.0M | $199.0M | $739.0M |
| Less: net income (loss) attributable to noncontrolling interests | $127.0M | $128.0M | — | — |
| Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $223.0M | $299.0M | $76.0M | $609.0M |
| Basic (in dollars per share) | $0.54 | $0.71 | $0.16 | $1.21 |
| Diluted (in dollars per share) | $0.54 | $0.70 | $0.16 | $1.19 |
| Basic (in shares) | 409.0M | 433.9M | 468.8M | 504.5M |
| Diluted (in shares) | 414.0M | 439.4M | 474.9M | 511.0M |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Premiums | $875.0M | $881.0M | $886.0M | $865.0M |
| Net investment income | $836.0M | $766.0M | $799.0M | $802.0M |
| Net investment gains (losses) | $37.0M | ($26.0M) | $99.0M | ($28.0M) |
| Policy fees and other income | $153.0M | $156.0M | $151.0M | $157.0M |
| Total revenues | $1.9B | $1.8B | $1.9B | $1.8B |
| Benefits and other changes in policy reserves | $1.2B | $1.2B | $1.2B | $1.2B |
| Liability remeasurement (gains) losses | $132.0M | $44.0M | $106.0M | $60.0M |
| Changes in fair value of market risk benefits and associated hedges | ($17.0M) | $10.0M | ($1.0M) | ($10.0M) |
| Interest credited | $96.0M | $95.0M | $96.0M | $94.0M |
| Acquisition and operating expenses, net of deferrals | $268.0M | $213.0M | $259.0M | $249.0M |
| Amortization of deferred acquisition costs and intangibles | $54.0M | $55.0M | $57.0M | $57.0M |
| Interest expense | $26.0M | $25.0M | $27.0M | $26.0M |
| Total benefits and expenses | $1.8B | $1.7B | $1.8B | $1.7B |
| Income (loss) from continuing operations before income taxes | $109.0M | $111.0M | $164.0M | $125.0M |
| Provision (benefit) for income taxes | $26.0M | $31.0M | $9.0M | $35.0M |
| Income (loss) from continuing operations | $83.0M | $80.0M | $155.0M | $90.0M |
| Income (loss) from discontinued operations, net of taxes | ($2.0M) | ($1.0M) | ($8.0M) | ($7.0M) |
| Net income (loss) | $81.0M | $79.0M | $147.0M | $83.0M |
| Less: net income (loss) attributable to noncontrolling interests | $34.0M | $32.0M | $31.0M | $32.0M |
| Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $47.0M | $47.0M | $116.0M | $51.0M |
| Basic (in usd per share) | $0.13 | $0.12 | $0.30 | $0.14 |
| Diluted (in usd per share) | $0.13 | $0.12 | $0.30 | $0.14 |
| Basic (in usd per share) | $0.12 | $0.12 | $0.29 | $0.12 |
| Diluted (in usd per share) | $0.12 | $0.12 | $0.28 | $0.12 |
| Basic (in shares) | 381.3M | 388.1M | 408.0M | 413.2M |
| Diluted (in shares) | 386.3M | 393.7M | 413.3M | 417.5M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Fixed maturity securities available-for-sale, at fair value (amortized cost of $48,150 and $48,720, respectively, and allowance for credit losses of $23 and $10, respectively) | $45.8B | — | — | — |
| Equity securities, at fair value | $555.0M | $515.0M | $396.0M | $319.0M |
| Commercial mortgage loans | $6.4B | — | — | — |
| Less: Allowance for credit losses | ($59.0M) | ($39.0M) | ($27.0M) | ($22.0M) |
| Commercial mortgage loans, net | $6.3B | $6.4B | $6.8B | $7.0B |
| Policy loans | $2.3B | $2.3B | $2.2B | $2.1B |
| Limited partnerships | $3.5B | $3.1B | $2.8B | $2.3B |
| Other invested assets | $770.0M | $648.0M | $731.0M | $566.0M |
| Total investments | $59.2B | $57.9B | $59.8B | $58.9B |
| Cash, cash equivalents and restricted cash | $2.0B | $2.0B | $2.2B | $1.8B |
| Accrued investment income | $603.0M | $607.0M | $647.0M | $643.0M |
| Deferred acquisition costs | $1.6B | $1.8B | $2.0B | $2.2B |
| Intangible assets and goodwill | $198.0M | — | — | — |
| Reinsurance recoverable | $17.9B | $17.7B | $19.1B | $16.5B |
| Less: Allowance for credit losses | ($23.0M) | ($24.0M) | ($29.0M) | ($60.0M) |
| Reinsurance recoverable, net | $17.8B | $17.7B | $19.0B | $16.4B |
| Other assets | $418.0M | $444.0M | $489.0M | $415.0M |
| Deferred tax asset | $1.8B | $1.7B | $2.0B | $1.3B |
| Market risk benefit assets | $64.0M | $57.0M | $43.0M | — |
| Separate account assets | $4.4B | $4.4B | $4.5B | $4.4B |
| Total assets | $88.1B | $86.9B | $90.8B | $86.4B |
| Future policy benefits | $55.2B | $53.6B | $57.7B | $38.1B |
| Policyholder account balances | $13.8B | $14.6B | $15.5B | $17.1B |
| Market risk benefit liabilities | $413.0M | $465.0M | $625.0M | — |
| Liability for policy and contract claims | $727.0M | $670.0M | $652.0M | $12.2B |
| Unearned premiums | $92.0M | $115.0M | $149.0M | $584.0M |
| Other liabilities | $2.1B | $2.0B | $1.8B | $1.7B |
| Long-term borrowings | $1.5B | $1.5B | $1.6B | $1.6B |
| Separate account liabilities | $4.4B | $4.4B | $4.5B | $4.4B |
| Liabilities related to discontinued operations | $0 | $4.0M | $0 | $8.0M |
| Total liabilities | $78.3B | $77.4B | $82.5B | $75.7B |
| Common stock, $0.001 par value; 1,500,000,000 shares authorized; 607,393,280 and 606,314,179 shares issued, respectively; 391,836,579 and 421,419,484 shares outstanding, respectively | 1.0M | 1.0M | 1.0M | 1.0M |
| Additional paid-in capital | $11.9B | $11.9B | $11.9B | $11.9B |
| Accumulated other comprehensive income (loss) | ($1.3B) | ($1.6B) | ($2.6B) | ($2.2B) |
| Retained earnings | $1.7B | $1.5B | $1.2B | $3.1B |
| Treasury stock, at cost (215,556,701 and 184,894,695 shares, respectively) | -3.5B | -3.3B | -3.1B | -2.8B |
| Total Genworth Financial, Inc.’s stockholders’ equity | $8.8B | $8.5B | $7.5B | $10.0B |
| Noncontrolling interests | $1.0B | $937.0M | $855.0M | $755.0M |
| Total equity | $9.8B | $9.4B | $8.3B | $10.7B |
| Total liabilities and equity | $88.1B | $86.9B | $90.8B | $86.4B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Fixed maturity securities available-for-sale, at fair value | $45.3B | $45.1B | $46.1B | — |
| Equity securities, at fair value | $564.0M | $544.0M | $546.0M | $516.0M |
| Commercial mortgage loans | $6.4B | $6.4B | $6.4B | $6.4B |
| Less: Allowance for credit losses | ($57.0M) | ($58.0M) | ($59.0M) | ($56.0M) |
| Commercial mortgage loans, net | $6.4B | $6.3B | $6.3B | $6.3B |
| Policy loans | $2.4B | $2.3B | $2.3B | $2.4B |
| Limited partnerships | $3.5B | $3.5B | $3.5B | $3.3B |
| Other invested assets | $871.0M | $770.0M | $658.0M | $643.0M |
| Total investments | $59.0B | $58.5B | $59.4B | $58.9B |
| Cash, cash equivalents and restricted cash | $2.0B | $2.1B | $2.0B | $1.8B |
| Accrued investment income | $555.0M | $633.0M | $589.0M | $556.0M |
| Deferred acquisition costs | $1.5B | $1.5B | $1.6B | $1.7B |
| Intangible assets and goodwill | $201.0M | $199.0M | — | — |
| Reinsurance recoverable | $17.4B | $17.4B | $17.9B | $17.7B |
| Less: Allowance for credit losses | ($21.0M) | ($21.0M) | ($23.0M) | ($23.0M) |
| Reinsurance recoverable, net | $17.4B | $17.4B | $17.9B | $17.6B |
| Other assets | $474.0M | $468.0M | $421.0M | $479.0M |
| Deferred tax asset | $1.8B | $1.8B | $1.8B | $1.7B |
| Market risk benefit assets | $79.0M | $55.0M | $62.0M | $58.0M |
| Separate account assets | $4.4B | $4.1B | $4.4B | $4.4B |
| Total assets | $87.4B | $86.8B | $88.5B | $87.3B |
| Future policy benefits | $54.5B | $54.1B | $55.4B | $54.1B |
| Policyholder account balances | $13.9B | $13.9B | $14.0B | $14.2B |
| Market risk benefit liabilities | $366.0M | $423.0M | $429.0M | $453.0M |
| Liability for policy and contract claims | $757.0M | $743.0M | $710.0M | $763.0M |
| Unearned premiums | $81.0M | $85.0M | $96.0M | $101.0M |
| Other liabilities | $2.1B | $2.1B | $2.1B | $2.1B |
| Long-term borrowings | $1.5B | $1.5B | $1.5B | $1.5B |
| Separate account liabilities | $4.4B | $4.1B | $4.4B | $4.4B |
| Total liabilities | $77.6B | $76.9B | $78.7B | $77.6B |
| Common stock | $1.0M | $1.0M | $1.0M | $1.0M |
| Additional paid-in capital | $11.9B | $11.9B | $11.9B | $11.9B |
| Accumulated other comprehensive income (loss) | ($1.3B) | ($1.2B) | ($1.4B) | ($1.4B) |
| Retained earnings | $1.8B | $1.7B | $1.7B | $1.6B |
| Treasury stock, at cost | ($3.6B) | ($3.6B) | ($3.4B) | ($3.3B) |
| Total Genworth Financial, Inc.’s stockholders’ equity | $8.7B | $8.8B | $8.8B | $8.8B |
| Noncontrolling interests | $1.0B | $1.0B | $1.0B | $991.0M |
| Total equity | $9.8B | $9.8B | $9.8B | $9.8B |
| Total liabilities and equity | $87.4B | $86.8B | $88.5B | $87.3B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income (loss) | $350.0M | $427.0M | $199.0M | $739.0M |
| Less (income) loss from discontinued operations, net of taxes | ($1.0M) | $10.0M | — | $0 |
| Amortization of fixed maturity securities discounts and premiums | ($138.0M) | ($119.0M) | ($106.0M) | ($154.0M) |
| Net investment (gains) losses | ($59.0M) | ($13.0M) | ($23.0M) | $17.0M |
| Changes in fair value of market risk benefits and associated hedges | $3.0M | ($13.0M) | ($12.0M) | — |
| Charges assessed to policyholders | ($540.0M) | ($564.0M) | ($572.0M) | ($596.0M) |
| Amortization of deferred acquisition costs and intangibles | $231.0M | $249.0M | $264.0M | $307.0M |
| Deferred income taxes | ($55.0M) | ($103.0M) | $48.0M | $235.0M |
| Derivative instruments, limited partnerships and other | ($316.0M) | ($461.0M) | ($557.0M) | ($335.0M) |
| Long-term incentive compensation expense | $58.0M | $51.0M | $49.0M | $37.0M |
| Accrued investment income and other assets | ($77.0M) | ($112.0M) | ($150.0M) | ($161.0M) |
| Insurance reserves | $908.0M | $777.0M | $1.5B | $863.0M |
| Current tax liabilities | ($30.0M) | $14.0M | $46.0M | ($1.0M) |
| Other liabilities, policy and contract claims and other policy-related balances | $5.0M | ($55.0M) | ($79.0M) | $129.0M |
| Cash from (used by) operating activities—discontinued operations | ($12.0M) | $0 | ($3.0M) | ($31.0M) |
| Net cash from (used by) operating activities | $327.0M | — | — | $1.0B |
| Fixed maturity securities | $2.9B | $2.5B | $2.4B | $2.7B |
| Commercial mortgage loans | $696.0M | $586.0M | $470.0M | $759.0M |
| Limited partnerships and other invested assets | $280.0M | $244.0M | $202.0M | $185.0M |
| Fixed maturity and equity securities | $2.1B | $2.6B | $2.2B | $2.7B |
| Fixed maturity and equity securities | ($4.3B) | ($4.4B) | ($3.2B) | ($4.0B) |
| Commercial mortgage loans | ($617.0M) | ($211.0M) | ($273.0M) | ($958.0M) |
| Limited partnerships and other invested assets | ($614.0M) | ($518.0M) | ($586.0M) | ($645.0M) |
| Short-term investments, net | ($31.0M) | $24.0M | ($12.0M) | $23.0M |
| Policy loans, net | $108.0M | $73.0M | $73.0M | $41.0M |
| Proceeds from sale of property | $23.0M | — | — | — |
| Other | ($50.0M) | ($56.0M) | ($55.0M) | — |
| Net cash from (used by) investing activities | $518.0M | $861.0M | $1.3B | $733.0M |
| Deposits to universal life and investment contracts | $505.0M | $534.0M | $566.0M | $606.0M |
| Withdrawals from universal life and investment contracts | ($991.0M) | ($1.2B) | ($1.6B) | ($1.7B) |
| Proceeds from issuance of long-term debt | $0 | $750.0M | — | $0 |
| Debt issuance costs | $0 | ($7.0M) | — | — |
| Repayment and repurchase of long-term debt | ($7.0M) | ($824.0M) | ($32.0M) | ($297.0M) |
| Repurchase of subsidiary shares | -72.0M | -45.0M | -16.0M | — |
| Treasury stock acquired in connection with share repurchases | ($247.0M) | ($189.0M) | ($296.0M) | ($64.0M) |
| Dividends paid to noncontrolling interests | ($23.0M) | ($21.0M) | ($39.0M) | ($46.0M) |
| Other, net | ($22.0M) | ($99.0M) | $11.0M | ($85.0M) |
| Net cash from (used by) financing activities | ($857.0M) | ($1.1B) | ($1.4B) | ($1.6B) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | $0 | ($1.0M) | $1.0M | $0 |
| Net change in cash, cash equivalents and restricted cash | ($12.0M) | ($167.0M) | $416.0M | $228.0M |
| Cash, cash equivalents and restricted cash at beginning of period | $2.0B | $2.2B | $1.8B | $1.6B |
| Cash, cash equivalents and restricted cash at end of period | $2.0B | $2.0B | $2.2B | $1.8B |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income (loss) | $160.0M | $79.0M | $315.0M | $168.0M |
| Less (income) loss from discontinued operations, net of taxes | $3.0M | $1.0M | $20.0M | $12.0M |
| Amortization of fixed maturity securities discounts and premiums | ($92.0M) | ($31.0M) | ($105.0M) | ($69.0M) |
| Net investment (gains) losses | ($11.0M) | $26.0M | ($98.0M) | $1.0M |
| Changes in fair value of market risk benefits and associated hedges | ($7.0M) | $10.0M | $7.0M | $8.0M |
| Charges assessed to policyholders | ($265.0M) | ($133.0M) | ($409.0M) | ($276.0M) |
| Amortization of deferred acquisition costs and intangibles | $109.0M | $55.0M | $174.0M | $117.0M |
| Deferred income taxes | $4.0M | $23.0M | ($29.0M) | ($20.0M) |
| Derivative instruments, limited partnerships and other | ($159.0M) | ($40.0M) | ($268.0M) | ($160.0M) |
| Long-term incentive compensation expense | $35.0M | $15.0M | $42.0M | $25.0M |
| Accrued investment income and other assets | ($69.0M) | ($75.0M) | ($60.0M) | ($50.0M) |
| Insurance reserves | $489.0M | $220.0M | $588.0M | $336.0M |
| Current tax liabilities | $0 | $8.0M | ($3.0M) | ($20.0M) |
| Other liabilities, policy and contract claims and other policy-related balances | ($50.0M) | ($66.0M) | ($19.0M) | ($11.0M) |
| Cash from (used by) operating activities—discontinued operations | ($4.0M) | ($1.0M) | ($28.0M) | ($21.0M) |
| Net cash from (used by) operating activities | $143.0M | $91.0M | $127.0M | $40.0M |
| Fixed maturity securities | $1.6B | $765.0M | $2.0B | $1.3B |
| Commercial mortgage loans | $364.0M | $147.0M | $486.0M | $313.0M |
| Limited partnerships and other invested assets | $161.0M | $65.0M | $173.0M | $102.0M |
| Fixed maturity and equity securities | $1.2B | $340.0M | $1.5B | $1.0B |
| Fixed maturity and equity securities | ($2.8B) | ($1.1B) | ($2.9B) | ($2.1B) |
| Commercial mortgage loans | ($408.0M) | ($132.0M) | ($415.0M) | ($259.0M) |
| Limited partnerships and other invested assets | ($264.0M) | ($127.0M) | ($330.0M) | ($226.0M) |
| Short-term investments, net | ($41.0M) | $8.0M | ($21.0M) | ($6.0M) |
| Policy loans, net | $1.0M | $0 | $93.0M | $52.0M |
| Other | ($28.0M) | ($12.0M) | ($25.0M) | ($15.0M) |
| Net cash from (used by) investing activities | ($177.0M) | ($5.0M) | $468.0M | $160.0M |
| Deposits to universal life and investment contracts | $549.0M | $292.0M | $383.0M | $258.0M |
| Withdrawals from universal life and investment contracts | ($376.0M) | ($197.0M) | ($773.0M) | ($562.0M) |
| Repayment and repurchase of long-term debt | ($15.0M) | ($5.0M) | $0 | $0 |
| Repurchase of subsidiary shares | -36.0M | -18.0M | -48.0M | -28.0M |
| Treasury stock acquired in connection with share repurchases | ($130.0M) | ($67.0M) | ($151.0M) | ($77.0M) |
| Dividends paid to noncontrolling interests | ($12.0M) | ($6.0M) | ($17.0M) | ($11.0M) |
| Other, net | $4.0M | ($1.0M) | ($1.0M) | ($31.0M) |
| Net cash from (used by) financing activities | ($16.0M) | ($2.0M) | ($607.0M) | ($451.0M) |
| Net change in cash, cash equivalents and restricted cash | ($50.0M) | $84.0M | ($12.0M) | ($251.0M) |
| Cash, cash equivalents and restricted cash at beginning of period | $2.0B | $2.0B | $2.0B | $2.0B |
| Cash, cash equivalents and restricted cash at end of period | $2.0B | $2.1B | $2.0B | $1.8B |
GENWORTH FINANCIAL INC score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.